Loading
Diagnosis information
Core diagnostic criteria, specifiers, differential considerations, and documentation support in one open, scan-friendly view.
All criteria are shown. No expand controls or hidden sections.
Core criterion A
Involuntary athetoid or choreiform movements (lasting ≥4 weeks) of the tongue, jaw, trunk, or extremities that developed in association with use of a neuroleptic medication
Core criterion B
Involuntary movements are present after neuroleptic medication dosage reduction or discontinuation
Consistent with [Tardive Dyskinesia] [specifier(s)]. After at least a few months of exposure to a dopamine receptor-blocking agent, there have been involuntary choreiform movements; athetoid movements; facial grimacing; lip smacking; tongue protrusion; chewing movements; limb or truncal writhing; pelvic or respiratory dyskinesias, forming a pattern consistent with a persistent, medication-induced hyperkinetic movement disorder. The presentation is further characterised by a typical distribution involving the orofacial region and/or distal limbs, fluctuating intensity, and persistence for at least one month after medication reduction or cessation where applicable. These symptoms have resulted in clinically significant distress or impairment, and are not better explained by primary neurological movement disorders, acute extrapyramidal syndromes, hypokinetic-rigid states, substance intoxication, or tardive akathisia.
Adapt this supplied template to the assessment. It is not a substitute for diagnostic reasoning or local documentation requirements.